Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice

por Ji, Pengmin, Shi, Qifeng, Liu, Yan, Han, Min, Su, Yong, Sun, Ran, Zhou, Huimin, Li, Weizu, Li, Weiping
Publicado 2023

Ginsenoside Rg1 treatment protects against cognitive dysfunction via inhibiting PLC–CN–NFAT1 signaling in T2DM mice

por Dong, Xianan, Kong, Liangliang, Huang, Lei, Su, Yong, Li, Xuewang, Yang, Liu, Ji, Pengmin, Li, Weiping, Li, Weizu
Publicado 2023

Ginsenoside Rg1 alleviates learning and memory impairments and Aβ disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice

por Li, Xuewang, Huang, Lei, Kong, Liangliang, Su, Yong, Zhou, Huimin, Ji, Pengmin, Sun, Ran, Wang, Chao, Li, Weiping, Li, Weizu
Publicado 2022